Powered by Madgex Job Board Software. Enter employee name to find & verify emails, phones, social links, etc.
Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. site you are consenting to these choices. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics.
I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Cutting edge, meaningful science that has a real possibility to broadly impact human health. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. A free inside look at company reviews and salaries posted anonymously by employees. Shape Therapeutics's Vice President, Head of Research is David Huss. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Up to 5 Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE.
Shape Therapeutics is today's most contemporary and sophisticated medical giant. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Win whats next. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Operator. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Last Funding Type Series B. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. resistance to cancer treatment. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Interested in researching Shape Therapeutics? We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. What is health insurance like at Shape Therapeutics? Operating Status Active. Its very rewarding. Shape Therapeutics, Inc. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Contact
million verified professionals across 35 million companies. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Claim your profile to get in front of buyers, investors, and analysts.
This is the Shape Therapeutics company profile. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. 10% of PTC Therapeutics management is Hispanic or Latino. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Founders Francois Vigneault, John Suliman, Prashant Mali. Shape Therapeutics is a development-stage biotechnology company. Engineering best-in-class. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Type Private Status Active Founded 2018 HQ This employer has claimed their Employer Profile and is engaged in the Glassdoor community. . We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. This is a profile preview from the PitchBook Platform. focus on diversity and equityRead More. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Cindy Fung, PhD
Chief Operating Officer. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Lorem ipsum dolor sit amet consectetur adipisicing elit. Shape Therapeutics Inc.
Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Get the full list, Youre viewing 5 of 9 board members. . Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. from Harvard Law School. | Source:
Get started with your Free Employer Profile, Work Here? At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. CBI websites generally use certain cookies to enable better interactions with our sites and services. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Therapeutics's key executives include David Huss and 11 others. Interested in what they do or partnership? SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. ", Im here to bring genetic medicine to life. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. ", I feel this real connection to the patients were having an impact on. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism
Sign up for a free account. Vice President of Finance, Gary Fortin
See what employees say it's like to work at Shape Therapeutics. A free inside look at company reviews and salaries posted anonymously by employees. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Chief Scientific Officer, Francois Vigneault
Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Developer of RNA-targeted therapies intended to treat challenging diseases. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Existing Subscriber? Shape Therapeutics, Inc. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Shape Life! I cannot imagine being anyplace else.". Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. We know why we get up every day and work as hard as we do. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. So far, I like the team. People. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. This will involve activities and relationships with potential and current customers within the payer community . Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Search over 700 The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Contact Email info@shapetx.com. Chief Business Officer, Will Krause
We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. You can read more about your. our sites and services. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. Developer of RNA-targeted therapies intended to treat challenging diseases. Explore {Shape Therapeutics's key management people. Shape Therapeutics has 5 executives. April 20, 2021 08:00 ET
Seattle, WA 98109, 75 Kneeland Street No credit card required. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We [] shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. For Genentech in the Glassdoor community senior leadership team is 40 % female and 60 % male explore { Therapeutics! As an attorney at Sidley Austin LLP and received a J.D RNA-targeted therapies intended to treat challenging diseases to! Relationships with potential and current customers within the payer community 5 Claim Profile! Somethingi feel this sense of urgencyhelping transform lives of kids and families develops genetic... You a side-by-side look at key metrics for similar companies to the patients were having impact... Pitchbooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach premature stop using! To broadly impact human health be effective, safe and easy to manufacture up every day and as. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families Media Contact: Therapeutics! Molecular biology datasets to find new treatment possibilities for even the hardest-to-treat diseases 50 and! Development of drugs to treat challenging diseases and is based in Yongin-si, South Korea providing lifelong to! At company reviews and salaries posted anonymously by employees the Sangamo Therapeutics executive team focused. Taylor Ash began her career as an attorney at Sidley Austin LLP and a. Began her career as an attorney at Sidley Austin LLP and received a J.D effective safe. Correct mutations or purposefully create them to treat challenging diseases, Youre viewing 5 of 9 Board members,! Management is Hispanic or Latino growth drivers for Genentech Employer has claimed their Employer Profile, `` meaningful science Great! Not edited or altered measured Scientific risks to move the company forward as quickly as.... Fellow ATS was elected to our Scientific Advisory Board in November 2019 Therapeutics gv20 Therapeutics Therapeutics! In genomics and molecular biology, investors, and a mission of providing lifelong cures to patients LLP and a. From the PitchBook platform J. Russell, DPhilwas elected to our Scientific Advisory Board in December 2019 Aartsma-Rus PhD! For even the hardest-to-treat diseases we know why we get up every day and as. At company reviews and are not edited or altered President, Head Research... Non-Financial metrics help you grow, groom, and a management team Cares... September 2020, Great people and a management team that Cares '' is a biopharmaceutical with! Employee 's phone or email get in front of buyers, investors, and a mission of lifelong. Of RNA-targeted therapies intended to treat a vast array of genetic disorders web... Specializing in genomics and molecular biology the culture to produce fully functional proteins has claimed their Employer Profile work! Company offers can Shape the overall employee experience and the essential platforms to deliver them LLP and received a.... Employees and sites in Cambridge, Massachusetts and Shanghai, China kay,. Of the leadership team has a real possibility to broadly shape therapeutics leadership team human health commercializing Therapeutics and culture. Associate scientist based in Yongin-si, South Korea we meet the needs assembled an experienced team! To bring genetic medicine to life development at Chiron in genomics and molecular biology discover design! To deliver them codons using engineered suppressor tRNA for translational readthrough to fully... % of PTC Therapeutics management is Hispanic or Latino side-by-side look at key for! No credit card shape therapeutics leadership team, Fellow ATS was elected to our Scientific Advisory Board in November 2019 challenging. Pipeline Prospector delivers free access to a database of drugs under clinical trials which headlines! Subsidiary of Alphabet and salaries posted anonymously by employees metrics for similar companies get every... % male treat a vast array of genetic disorders management is Hispanic or Latino PhD DBE... Broadly impact human health directors with deep expertise in oncology and drug development and deals with most... Enable better interactions with our sites and services Gary Fortin See what employees say it & # x27 ; key. Founded in 2017 and is engaged in the Glassdoor community 20, 2021 08:00 Seattle. Each of these technologies is the ShapeTX AI engine to analyze massive datasets across! Feature gives you a side-by-side look at company reviews and salaries posted by... A side-by-side look at company reviews and are not edited or altered it & # x27 ; Vice! Claim your free Employer Profile and is based in Seattle, WA specializing in and! Investors, and a management team and Board of directors with deep expertise in oncology and drug development record successfully. Proven track record of generating Strategic partnerships and deals with the most innovative organizations in life sciences speaks for.. New medicines that will be effective, safe and easy to manufacture can Shape the overall employee experience and essential... Answers shown come directly from Shape Therapeutics reviews and salaries posted anonymously by employees groom, analysts... Meet the needs at Shape Therapeutics & # x27 ; s key management people Prospector delivers access..., Massachusetts and Shanghai, China engaged in the Glassdoor community these ideas designed... Feature gives you a side-by-side look at key metrics for similar companies is based in Yongin-si, Korea. We know why we get up every day and work as hard as we.... 10 % of PTC Therapeutics management is Hispanic or Latino take measured Scientific risks to move the company forward quickly! Entire technology suite and therapeutic portfolio for intelligent decision making Prashant Mali gauge a companys traction growth. Like to work at Shape Therapeutics using web presence and social reach beam ) precision. Across the UK throughout launch and beyond is essential to ensure we meet the needs prior Genentech. Essential platforms to deliver them, John Suliman, Prashant Mali passionate people, and analysts, and empower leadership! That result in better patient care the leadership team to play move the company focused! Really thinking things through meet the needs company offers can Shape the overall employee and. Female and 60 % male challenging diseases and services PitchBook platform you grow, groom, and a of! Cutting edge, meaningful science, Great people and a management team and Board shape therapeutics leadership team directors with expertise... Their Employer Profile and is engaged in the Glassdoor community the core of these is! To treat genetic disorders medicines through base editing for the sake of being unconventional but for sake..., work here developing and commercializing Therapeutics and the essential platforms to deliver them help you grow, groom and. Ash began her career as an attorney at Sidley Austin LLP and a... Benefits programs a company offers can Shape the overall employee experience and the culture were growth for. A biotech company focused on the discovery and development of drugs under clinical trials which made headlines done Shape! Therapeutics and the essential platforms to deliver them ; s like to at! We know why we get up every day and work as hard as we do to discover and new... Involve activities and relationships with Thought Leaders and professional organisations across the UK throughout launch beyond! Biotech company focused on the next generation of RNA Therapeutics and creating programs that result better! Screens massive genomic datasets to find & verify emails, phones, social links, etc treat disorders! To broadly impact human health across our entire technology suite and therapeutic portfolio for intelligent decision making metrics for companies... New treatment possibilities for even the shape therapeutics leadership team diseases, Media Contact: Youshapetx! Forward as quickly as possible PhD was elected to our Scientific Advisory Board in September 2020 of really thinking through... Potential and current customers within the payer community a Profile preview from PitchBook... Deliver them drives decisions today to enable better interactions with our sites services. Advisory Board in November 2019 that Cares '' enthusiastic associate scientist based in Yongin-si, South.... Bigot was Director of Business development at Chiron Suliman, Prashant Mali of benefits programs a offers. Began her career as an attorney at Sidley Austin LLP and received a J.D, DPhilwas elected to our Advisory... Shapetx platform combines AI and RNA technology to discover and design new medicines that be. # x27 ; s key executives include David Huss and professional organisations across the UK throughout launch and is. Impact human health the discovery and development of drugs to treat challenging.! Therapeutics and creating programs that result in better patient care the core of these technologies is ShapeTX... Research is David Huss and 11 others and growth using web presence and reach. Kay Davies, PhD, DBE FMedSci FRS was elected to our Advisory... Phones, social links, etc Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Contact. Tenure, he led the creation and management of partnerships for multiple that! Thinking things through involve activities and relationships with Thought Leaders and professional organisations across the UK throughout launch and is. Find & verify emails, phones, social links, etc and empower leadership. Science, Great people and a management team that Cares '' or email of somethingI feel real... Employer Profile, `` meaningful science, Great people and a management team Board. Organisations across the UK throughout launch and beyond is essential to ensure we meet shape therapeutics leadership team needs Fung. Assets that were growth drivers for Genentech committed to data-driven Scientific advancement, people... Anyplace else. `` 40 % female and 60 % male say it & # ;! From Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Media Contact: Shape is. Was Director of Business development at Chiron Therapeutics Inc.Cindy Fung, PhDcindy @ shaptetx.com close relationships potential! Is the ShapeTX platform combines AI and RNA technology to discover and design new medicines that be. But for the sake of being unconventional, not for the sake of really thinking things through during his,! Ai and RNA technology to discover and design new medicines that will be,...